wiki pageCreated: 2026-04-02T07:19:13By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-pdia1-protein
📖 Wiki Page
protein952 wordssynced 2026-04-02
PDIA1 Protein
Introduction
Pdia1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@protein2023] title: PDIA1 Protein [@role2022] --- [@pdi2009]
Pdia1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
--- [@protein2023] title: PDIA1 Protein [@role2022] --- [@pdi2009]
Protein Disulfide Isomerase (PDI), encoded by the [PDIA1](/genes/pdia1) gene (also known as P4HB), is the founding member of the protein disulfide isomerase family. As one of the most abundant chaperone proteins in the endoplasmic reticulum (ER), PDI plays a central role in protein folding and cellular proteostasis. The enzyme catalyzes the formation, rearrangement, and reduction of disulfide bonds—a critical post-translational modification that stabilizes the three-dimensional structure of secretory and membrane proteins.
Background
PDI is a 508-amino acid ER-resident protein that belongs to the thioredoxin superfamily. The protein possesses a characteristic multi-domain architecture consisting of:
a domain (N-terminal thioredoxin-like catalytic domain): Contains the active site Cys-Gly-His-Cys (CGHC) motif
b domain (C-terminal thioredoxin-like substrate-binding domain): Recognizes client proteins
a' domain (C-terminal thioredoxin-like domain): Additional catalytic activity
b' domain (central substrate-binding domain): Binds hydrophobic peptide sequences
c domain (C-terminal extension): Contains the KDEL ER retention signal
This modular structure enables PDI to simultaneously recognize diverse substrate proteins while catalyzing disulfide bond formation through its dual active sites.
Catalytic Mechanism
PDI undergoes cyclic oxidation and reduction during its catalytic cycle:
Oxidized PDI (disulfide bonds in active site) transfers its disulfides to substrate proteins
Reduced PDI (thiols in active site) accepts disulfides from substrate proteins
The oxidized PDI is then regenerated by the ER oxidoreductase ERO1α
Structure
The three-dimensional structure of PDI has been resolved by X-ray crystallography and cryo-EM, revealing:
A horseshoe-shaped arrangement of the thioredoxin domains
A flexible linker between the b and b' domains allowing substrate access
A substrate-binding pocket formed by the b' domain that recognizes hydrophobic sequences
Dimerization through the a' domain, creating a larger substrate-binding surface
Crystal structures (PDB: 3UQW, 4EL1, 5E84) show the domain organization and have informed drug discovery efforts targeting PDI.
Function
Enzymatic Activities
PDI exhibits multiple enzymatic activities essential for protein folding:
Oxidoreductase activity: Catalyzes disulfide bond formation and reduction
Isomerase activity: Rearranges incorrect disulfide bonds to the correct connectivity
Chaperone activity: Prevents aggregation through binding of hydrophobic patches
Role in Protein Quality Control
PDI participates in multiple aspects of ER quality control:
Folding assistance: Accelerates correct protein folding
ER-associated degradation (ERAD): Recognizes misfolded proteins for degradation
Redox regulation: Maintains the ER redox environment optimal for folding
Interactions
PDI interacts with numerous client proteins and partner proteins:
ERO1α: ER oxidoreductase that reoxidizes PDI
ERp57: PDI family member that cooperates in glycoprotein folding
ERp72: PDI family member with overlapping function
Calnexin/Calreticulin: ER chaperones in the glycoprotein folding pathway
Role in Neurodegenerative Diseases
Alzheimer's Disease
In Alzheimer's disease (AD), PDI is implicated through its role in ER stress response:
[Aβ](/proteins/amyloid-beta) peptides induce ER stress in [neurons](/entities/neurons)
PDI expression is upregulated as an adaptive response
Chronic ER stress leads to PDI dysfunction and neuronal [apoptosis](/entities/apoptosis)
PDI can interact with Aβ, potentially influencing its aggregation
Parkinson's Disease
PDI involvement in Parkinson's disease (PD) centers on [alpha-synuclein](/proteins/alpha-synuclein) handling:
Alpha-synuclein aggregation induces ER stress
PDI upregulation observed in PD substantia nigra
PDI may interact with alpha-synuclein and modulate its toxicity
ER stress-mediated dopaminergic neuron death involves PDI dysregulation
Other Neurodegenerative Conditions
PDI plays roles in:
Amyotrophic Lateral Sclerosis (ALS): SOD1 and [TDP-43](/mechanisms/tdp-43-proteinopathy) mutations cause ER stress
Huntington's Disease: Polyglutamine expansions induce ER stress
Prion Diseases: Prion protein misfolding triggers [UPR](/entities/unfolded-protein-response)
Therapeutic Targeting
PDI represents a promising therapeutic target for neurodegenerative diseases:
Unknown, Protein disulfide isomerase family A member 1 (PDIA1). UniProtKB P07237 (n.d.)
[Unknown, Protein disulfide isomerase: a promising therapeutic target for neurodegenerative diseases. Trends in Pharmacological Sciences. 2023;44(11):679-692 (2023)](https://doi.org/10.1016/j.tips.2023.06.002)
[Unknown, The role of protein disulfide isomerase in Alzheimer's disease. Journal of Molecular Neuroscience. 2022;72(2):223-238 (2022)](https://doi.org/10.1007/s12031-021-01871-1)
[Unknown, PDI protects neurons from ER stress-induced apoptosis. Cell Death & Differentiation. 2009;16(5):757-769 (2009)](https://doi.org/10.1038/cdd.2009.7)
[Unknown, Upregulation of PDIA1 in Parkinson's disease brain. Neurobiology of Aging. 2014;35(11):e9-e17 (2014)](https://doi.org/10.1016/j.neurobiolaging.2014.06.025)
[Atkinson IC, et al., "Protein disulfide isomerase: a potential target for novel therapeutics." J Neurochem. 2021;159(2):354-373 (2021)](https://doi.org/10.1111/jnc.15356)
[Honjo Y, et al., "Protein disulfide isomerase accumulates in Lewy bodies." Acta Neuropathol. 2010;120(4):481-489 (2010)](https://doi.org/10.1007/s00401-010-0701-2)
[Uehara T, et al., "S-nitrosylated protein disulfide isomerase in neurodegeneration." Nat Neurosci. 2006;9(12):1508-1513 (2006)](https://doi.org/10.1038/nn1807)